University of Michigan Health-West, formerly known as Metro Health – University of Michigan Health, is a nonprofit health system affiliated with University of Michigan Health, with primary and specialty care services at 30 locations in West Michigan.

There are 208 beds in Metro Health Hospital.

During the past decade, Metro Health Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metro Health Hospital" #1 sponsor was "SWOG Cancer Research Network" with 25 trials, followed by "Metro Health, Michigan" with 3 trials sponsored, "Penumbra Inc." with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "C. R. Bard" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metro Health Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Metro Health Hospital" are "Breast Cancer" (4 trials), "Lung Cancer" (4 trials), "Prostate Cancer" (4 trials), "Esophageal Cancer" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Metro Health Hospital" in a lesser frequency.

Most popular intervention types in "Metro Health Hospital" are "Drug" (33 trials), "Biological" (11 trials), "Procedure" (11 trials), "Radiation" (9 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (7 trials), "cisplatin" (6 trials), "radiation therapy" (6 trials), "cyclophosphamide" (5 trials) and "cetuximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Metro Health Hospital" are 39 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Metro Health Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Metro Health Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Metro Health Hospital, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Metro Health Hospital has several departments that took part in Clinical trials: "Metro Health Cancer Care" - 7 trials, "Metro Health Hospital Endoscopy Unit" - 2 trials